Abbott Laboratories (ABT)
NYSE·Healthcare·Medical - Devices
$93.53
+0.80%
Mkt Cap $166.85B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 16, 2026 | $11.00B | $11.16B | +1.49% | $1.14 | $1.15 | +0.88% | — | — |
| Q1 2026 Jan 22, 2026 | $11.80B | $11.46B | -2.89% | $1.50 | $1.50 | +0.00% | — | — |
| Q4 2025 Oct 15, 2025 | $11.39B | $11.37B | -0.18% | $1.30 | $1.30 | +0.00% | — | — |
| Q3 2025 Jul 17, 2025 | $11.09B | $11.14B | +0.45% | $1.26 | $1.26 | +0.00% | — | — |
| Q2 2025 Apr 16, 2025 | $10.41B | $10.36B | -0.46% | $1.07 | $1.09 | +1.87% | — | — |
| Q1 2025 Jan 22, 2025 | $11.03B | $10.97B | -0.52% | $1.34 | $1.34 | +0.00% | — | — |
| Q4 2024 Oct 16, 2024 | $10.55B | $10.63B | +0.80% | $1.20 | $1.21 | +0.83% | — | — |
| Q3 2024 Jul 18, 2024 | $10.37B | $10.38B | +0.08% | $1.10 | $1.14 | +3.64% | — | — |
| Q2 2024 Apr 17, 2024 | $9.88B | $9.96B | +0.82% | $0.95 | $0.98 | +2.62% | — | — |
| Q1 2024 Jan 24, 2024 | $10.18B | $10.24B | +0.60% | $1.19 | $1.19 | +0.00% | — | — |
| Q4 2023 Oct 18, 2023 | $9.61B | $10.14B | +5.50% | $1.10 | $1.14 | +3.64% | — | — |
| Q3 2023 Jul 20, 2023 | $9.70B | $9.98B | +2.88% | $1.04 | $1.08 | +3.85% | — | — |
| Q2 2023 Apr 19, 2023 | $9.64B | $9.75B | +1.15% | $0.98 | $1.03 | +5.10% | — | — |
| Q1 2023 Jan 25, 2023 | $9.66B | $10.09B | +4.41% | $0.90 | $1.03 | +14.44% | — | — |
| Q4 2022 Oct 19, 2022 | $9.65B | $10.41B | +7.89% | $0.91 | $1.15 | +26.37% | — | — |
| Q3 2022 Jul 20, 2022 | $10.33B | $11.26B | +9.02% | $1.13 | $1.43 | +26.55% | — | — |
| Q2 2022 Apr 20, 2022 | $11.00B | $11.89B | +8.17% | $1.47 | $1.73 | +17.69% | — | — |
| Q1 2022 Jan 26, 2022 | $11.09B | $11.47B | +3.44% | $1.21 | $1.32 | +9.09% | — | — |
| Q4 2021 Oct 20, 2021 | $9.44B | $10.93B | +15.72% | $0.95 | $1.40 | +47.37% | — | — |
| Q3 2021 Jul 22, 2021 | $9.45B | $10.22B | +8.18% | $1.01 | $1.17 | +15.84% | — | — |